Biotechnology Business
Kendall Law Group Investigates Valeant Pharmaceuticals International Merger for Shareholders
Published in Pharma Law Weekly, July 6th, 2010
Kendall Law Group, a national securities firm led by a former federal judge and a former U.S. Attorney, is investigating Valeant Pharmaceuticals International (NYSE: VRX) for shareholders in connection with the proposed merger with Biovail. The firm's investigation seeks to determine whether Valeant and its Board breached their fiduciary duties by entering into the agreement without properly shopping for a deal that would provide better value for shareholders. If you are a Valeant shareholder and would like additional information about your rights, contact the Kendall Law Group at 877-744-3728 or by email at jmckey@kendalllawgroup.com.
On June 21, 2010, the companies...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Law Weekly
Source: Pharma Law Weekly (2010-07-06)
More Articles from Pharma Law Weekly
- Social Science
Scientists at University of Nevada detail research in social science - Peptide Hormones
Akdeniz University, Medical Department publishes research in peptide hormones - AMRI
AMRI CFO to Present at Wells Fargo Securities Healthcare Conference - AMRI
AMRI Announces $10 Million Share Repurchase Program - More from this issue of Pharma Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
